In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni - Wikidata - awgldk - TriplyDB

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

http://www.wikidata.org/entity/Q33807299

about

CRISPR-Cas Genome Surgery in Ophthalmology.CRISPR Editing Technology in Biological and Biomedical Investigation.CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.A Broad-Spectrum Inhibitor of CRISPR-Cas9.Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism.Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods.Immunity to CRISPR Cas9 and Cas12a therapeutics.A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for Light-Inducible Gene Editing and Transcription.In vivo genome editing improves motor function and extends survival in a mouse model of ALS.In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells.Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.Current status and perspectives of genome editing technology for microalgae.Efficient Generation of Genome-Modified Mice Using Campylobacter jejuni-Derived CRISPR/Cas.Type II-C CRISPR-Cas9 Biology, Mechanism, and Application.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.RNA-dependent RNA targeting by CRISPR-Cas9.Genetically engineered pigs as models for human disease.In vivo genome editing thrives with diversified CRISPR technologies.Genome Surgery and Gene Therapy in Retinal Disorders.The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition.CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration.Gene therapy and genome surgery in the retina.Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells.The CRISPR tool kit for genome editing and beyond.In Vivo Applications of CRISPR-Based Genome Editing in the Retina.CRISPR/Cas9 genome surgery for retinal diseases All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo Minimal PAM specificity of a highly similar SpCas9 ortholog In Vivo Genome Editing as a Therapeutic Approach Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9 Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang

P2860

Q33745403-4BCAB80F-69C4-4932-B4BE-163FEE99785C Q38688945-20C7BCD2-C093-4D79-B528-3C360545412D Q38716317-E01902B7-04F7-4254-AB87-C320017741C9 Q40068953-0583EBE9-D8B2-4D81-8943-BFCAA05CF3A6 Q40120224-CC3DFB9D-28E2-4742-8785-2012DF066EFE Q41430829-56A64376-67CE-4A6D-B609-6B5E91438B5D Q45873745-7AB815A6-8F7F-4835-A78B-1BEFA3125988 Q45981156-A2AECAC3-CC95-4AD0-88F2-549BF4845823 Q47153099-D8935E49-633E-4D70-9787-4C892877392D Q47161048-362391BF-7FAB-4AEC-8AF5-C90499DBD99E Q47162699-B0385467-8C07-4647-80A2-7812B31E93AC Q47198422-7E656BB4-64FD-4037-8676-862F4F3AC24C Q47226763-DC073D41-B15C-48F9-AD78-1EE06C0DC0EB Q47240267-988FE530-1173-4FB7-ACCF-831590A0BB46 Q47334186-D91AD51F-5299-4B56-8AAE-557BE5646264 Q47553772-8B5B7D27-C623-4C77-8EC2-851BE8113ED3 Q47594697-A2F8367B-E97C-4966-8FE8-5D9C921A06DF Q48304493-C6DA75CA-FF49-4AC4-A0F8-10300BBC3993 Q50107614-EA8333CA-E845-4D31-8CEA-33932D42B942 Q52363995-599D9EF6-B516-48F0-8A23-08A7129DA178 Q52429662-1ED0E179-4594-472E-9B9D-8674B6E70CF3 Q52429663-064D82F3-84A8-49B8-BE75-62F09645D66E Q52429670-C884BBB6-5749-4D36-A06F-65FEE0B78870 Q52430557-F70EC0C9-E5B7-4CD3-9C82-7AA9B1AF8755 Q52430644-C08AA157-D9EE-4F77-8AE1-B0B3FCF64D32 Q52430861-8B26FEBA-FC99-4BB8-9B8B-87AEB29BFC03 Q52431312-236805DB-AC52-4BE2-93E3-105202E6D580 Q54941286-478AA003-A73C-48C0-BDCD-0D9C8D6317AE Q54977409-1E34DA97-28D0-4752-A56D-37A02B0A18AE Q55000684-A4FC536E-8309-4752-8519-09A3FCE5A61B Q55069666-D24EFC67-B424-4A19-A5B7-F4A75A3BDC4E Q55233775-DB13C4A9-AF9E-4F24-AF6A-9DCF6B0BB858 Q55262727-95C808E6-6016-4441-BFDA-F4DCCF6A6709 Q57171979-AE8B962A-8860-48DE-B179-4F7AE36FD917 Q58324031-0E3BBB8F-802B-49EF-9258-C93C18DC4EE4 Q58569539-0C33C7F1-33A4-4BC6-A05D-48C5A231A5D5 Q58745391-F25389E2-E965-4B02-BD6B-A4E311265361 Q58750557-2BE2E70E-2122-4C9B-AB02-A9A20AABD690 Q58759613-9CDB7E4B-3D26-4AC5-AA1C-028D04B05640

P2860

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

http://www.wikidata.org/entity/Q33807299

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@ast

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@en

type

label

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@ast

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@en

prefLabel

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@ast

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@en

P1433

Q33807299-765ABFDA-E3A5-4094-B9AB-A07A74E7783E

P1476

Q33807299-4E35C0BF-2E65-41F2-AA95-7C195653C7F2

P2093

Q33807299-07B63B9E-B7C1-4330-8E9A-555808B7891E

Q33807299-15AEE291-7BE9-43AB-B060-0A646D18547F

Q33807299-4D934D69-35BC-476A-B13A-A3DD96DE099D

Q33807299-5221B736-CDC2-4CB3-B3EF-449CE1DDF990

Q33807299-60E9EE9F-6299-43F3-8D45-E30FA74C0A65

Q33807299-76B74A7E-8A86-46D1-BEE3-70A2EDB3F6DA

Q33807299-7804851C-059F-442B-B9EB-2F28A10FCD7D

Q33807299-87732621-0664-4F9D-93BC-D07FC0B56067

Q33807299-9F4FC596-930E-4448-8328-E5EE636A252F

Q33807299-A83AE8C9-6ECB-4AB3-955E-1BE3D3E26F11

P2860

Q33807299-09A79EC6-A837-40B7-9CC2-38551A9D83D4

Q33807299-0B5F1C16-529B-45E1-89B6-19C114EDCBCA

Q33807299-0B99FF04-C8B8-4F0E-8347-52BD8EF50836

Q33807299-16BC8F58-1266-471B-A193-E585E51DC2AC

Q33807299-22E5333A-01FC-4416-8C2E-B379D9BF0FEA

Q33807299-30523429-7FC5-407F-83A0-A7BF9289E3C0

Q33807299-40065D96-70C8-4303-809A-37DA66D1DDE3

Q33807299-554F164E-23EC-47BD-B229-39D413B1FD44

Q33807299-5777800A-B184-4CA1-B519-5D159BCCED23

Q33807299-6144526C-78ED-411F-8F3E-3713381A2030

P2888

Q33807299-FD41884D-596E-41F4-BB17-60DC984CA04F

P304

Q33807299-E38D0B08-C5DB-4983-A985-CF1EE91E15E9

P31

Q33807299-70A1CB67-80E2-47DB-AACB-C59FB5AB7C31

P356

Q33807299-B70ECD05-BE7B-42D6-AB7D-2FB175A4EE2A

P407

Q33807299-351FBDF8-EBA4-440B-9A27-084B964DD198

P478

Q33807299-CF7020AC-8BCF-4145-8704-677B51B6E791

P50

Q33807299-2B8C9EBA-B7FD-4341-86C5-5BE4CF21FA18

P577

Q33807299-155A4D06-5A5F-47AD-8759-CA87EE54EA2C

P6179

Q33807299-D3B4C3B9-4DE7-4151-96FA-DDA29F80E976

P698

Q33807299-DB15C8EB-2272-479A-B4A5-310B1D106322

P921

Q33807299-AFD4FA4B-A4F2-4086-B870-0FD2D9838F1D

P932

Q33807299-142941E7-54FA-4AC9-B781-BC367FF2BD7B

P356

P1433

Nature Communications

P1476

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

@en

P2093

Daesik Kim

http://www.w3.org/2001/XMLSchema#string

Dong Woo Song

http://www.w3.org/2001/XMLSchema#string

Eunji Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Yeon Cho

http://www.w3.org/2001/XMLSchema#string

Jeong Hun Kim

http://www.w3.org/2001/XMLSchema#string

Jin Hyoung Kim

http://www.w3.org/2001/XMLSchema#string

Kyoungmi Kim

http://www.w3.org/2001/XMLSchema#string

Kyu Jun Lee

http://www.w3.org/2001/XMLSchema#string

Min Hee Jung

http://www.w3.org/2001/XMLSchema#string

Seokjoong Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease

RNA-programmed genome editing in human cells

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

Targeted deletion of Vegfa in adult mice induces vision loss

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

VEGF is major stimulator in model of choroidal neovascularization.

P2888

P304

14500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS14500

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083852488

http://www.w3.org/2001/XMLSchema#string

P698

28220790

http://www.w3.org/2001/XMLSchema#string

P921

P932

5473640

http://www.w3.org/2001/XMLSchema#string